Negative epidemiological association between HSV-1 and HSV-2 infections

被引:3
|
作者
Nasrallah, Gheyath K. [1 ,2 ]
Dargham, Soha R. [3 ]
Abu-Raddad, Laith J. [3 ,4 ,5 ]
机构
[1] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar
[2] Qatar Univ, BioMed Res Ctr, Doha, Qatar
[3] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar
[4] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med, New York, NY 10021 USA
[5] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar
关键词
Virology; Epidemiology; Infectious disease; Prevalence; Asia; Interaction; Herpes; Sexually transmitted infection; Middle East and North Africa; Serological testing; Epidemiological association; SIMPLEX-VIRUS TYPE-1; GENITAL HERPES; BLOOD-DONORS; MIDDLE-EAST; SEROPREVALENCE; PERFORMANCE; ANTIBODIES; TRENDS; ASSAYS; HBV;
D O I
10.1016/j.heliyon.2019.e02549
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: Existing evidence on an epidemiological association between herpes simplex virus (HSV) type 1 and type 2 infections remains conflicting and inconclusive. Using a multi-national database of HSV-1/2 serological testing, we aimed to assess the existence of an association between both infections. Design, Setting, and Participants: An HSV-1/2 cross-sectional serological testing database was assembled by merging databases of seroprevalence studies on men blood donors residing currently in Qatar, but from different countries. Specimens were tested for anti-HSV-1 IgG antibodies using HerpeSelect (R) 1 ELISA, and for anti-HSV-2 IgG anti-bodies following a two-test algorithm: HerpeSelect (R) 2 ELISA to test the sera, and Euroline-WB to confirm positive and equivocal specimens. Logistic regressions were conducted to estimate unadjusted and adjusted infection odds ratios. Results: Serological testing for HSV-1/2 was performed on 2522 specimens. Sero-positivity for HSV-1 and HSV-2 was identified in 2053 (81.5%) and 87 (3.5%) specimens, respectively. Univariable analyses estimated higher odds of HSV-2 infection with increasing age and increasing country income level, and an unadjusted odds ratio with HSV-1 sero-positivity of 0.71 (95% CI 0.43-1.17; p-value 0.172). Adjusting for age and country income level, the adjusted odds ratio of HSV-2 infection with HSV-1 sero-positivity was 0.51 (95% CI 0.30-0.87; p-value 0.013). Sensitivity analyses confirmed this association. Conclusions: There is a negative association between HSV-1 and HSV-2 infections, suggestive of a protective effect for HSV-1 sero-positivity against HSV-2 acquisition. This finding supports earlier pooled but inconclusive evidence from prospective studies, yet contrasts with pooled findings of earlier cross-sectional studies.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] HSV-1 as well as HSV-2 is frequent in oral mucosal lesions of children on chemotherapy
    Aggarwal, Ritu
    Bansal, Deepak
    Naru, Jasmine
    Salaria, Manila
    Rana, Anita
    Minz, Ranjana W.
    Trehan, Amita
    Marwaha, R. K.
    SUPPORTIVE CARE IN CANCER, 2014, 22 (07) : 1773 - 1779
  • [32] Different Mechanisms Regulate Productive Herpes Simplex Virus 1 (HSV-1) and HSV-2 Infections in Adult Trigeminal Neurons
    Bertke, Andrea S.
    Ma, AyeAye
    Margolis, Mathew S.
    Margolis, Todd P.
    JOURNAL OF VIROLOGY, 2013, 87 (11) : 6512 - 6516
  • [33] A comparison of referral patterns and characteristics of patients with first episode symptomatic genital HSV-1 and HSV-2 infections in Sheffield
    Nageswaran, A
    Shen, RN
    Craig, J
    Kyi, TT
    Priestley, CJF
    Kinghorn, GR
    GENITOURINARY MEDICINE, 1996, 72 (03): : 206 - 209
  • [34] Clinical features and therapeutic management of herpes simplex virus 1 and 2 (HSV-1 and HSV-2) infections: what'up in 2020?
    Boutolleau, David
    Burrel, Sonia
    VIROLOGIE, 2020, 24 (05) : 281 - 282
  • [35] Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs
    Kern, ER
    Palmer, J
    Szczech, G
    Painter, G
    Hostetler, KY
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2000, 19 (1-2): : 501 - 513
  • [36] Design and Development of a Fully Automated Assay for Detection and Differentiation of HSV-1 and HSV-2: The IMDx HSV-1/2 for Abbott m2000
    Bradley, S.
    Reiske, H.
    Salcius, J.
    Lauzier, B.
    Laslin, C.
    Jacobs, A.
    Del Mastro, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 694 - 694
  • [37] Genital HSV-1 infections
    Wald, A
    SEXUALLY TRANSMITTED INFECTIONS, 2006, 82 (03) : 189 - 190
  • [38] Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales
    Morris, MC
    Edmunds, WJ
    Hesketh, LM
    Vyse, AJ
    Miller, E
    Morgan-Capner, P
    Brown, DWG
    JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (04) : 522 - 527
  • [39] Analysis of HSV1/2 Infection Reveals an Association between HSV-2 Reactivation and Pregnancy
    Dovrat, Sara
    Shabat, Adar
    Yahav-Dovrat, Anat
    Soufiev, Zvia
    Mendelson, Ella
    Kashi-Zagdoun, Ela
    Rahav, Galia
    VIRUSES-BASEL, 2024, 16 (09):
  • [40] A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections
    Chiuppesi, Flavia
    Vannucci, Laura
    De Luca, Anna
    Lai, Michele
    Matteoli, Barbara
    Freer, Giulia
    Manservigi, Roberto
    Ceccherini-Nelli, Luca
    Maggi, Fabrizio
    Bendinelli, Mauro
    Pistello, Mauro
    JOURNAL OF VIROLOGY, 2012, 86 (12) : 6563 - 6574